跳至主要内容
临床试验/TCTR20221102001
TCTR20221102001已完成2 期

The effects of Hibiscus sabdariffa L calyces aqueous extract on insulin resistance in metabolic syndrome volunteers

/A0 个研究点目标入组 108 人开始时间: 2022年11月2日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
108

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 Years 至 70 Years(—)
性别
All

入选标准

  • 1. Individuals with metabolic syndrome diagnosed by the presence of central obesity (waist circumference greater than 90 cm (men) or greater than 80 cm (women)) and two of the following criteria: (1) fasting triglyceride (TG) level greater than or equal to 150 mg/dl (2) fasting high-density lipoprotein (HDL) cholesterol level 0 - 40 mg/dl (men) or 0 - 50 mg/dl (women) (3) systolic blood pressure greater than or equal to 130 mm Hg or diastolic blood pressure greater than or equal to 85 mm Hg (4) fasting blood glucose 100 - 125 mg/dl
  • 2. Non-smoker or quit smoking more than 6 months
  • 3. Willing to stop taking dietary supplements which affected study outcomes for 4 weeks prior to study entry
  • 4. Individuals who were agreeing to participate in the study and willing to provide written informed consent

排除标准

  • 1. Known allergy to Hibiscus sabdariffa
  • 2. Consumption of anthocyanin-rich sources during the study (blueberries, strawberries, bilberries, cranberries, elderberries, raspberries, mulberries, grapes, purple sweet potato, red cabbage, eggplant, red radish, pomegranate, rice berry, purple corn, and wine) more than 3 times per week
  • 3. Alcohol consumption of more than 1 standard drink per day or more than 7 standard drinks per week (woman) and more than 2 standard drinks per day or more than 14 standard drinks per week (man)
  • 4. Individuals with hypertension who are receiving hydrochlorothiazide, losartan, captopril, and amlodipine
  • 5. Individuals with dyslipidemia who are receiving statin (simvastatin)
  • 6. Individuals who are taking chloroquine
  • 7. Individuals with SARS-CoV-2 infection
  • 8. Individuals diagnosed with cardiovascular disease, type I and type II diabetes mellitus, and gout
  • 9. Levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT) and/or alkaline phosphatase (ALP) were out of normal range or suffering from hepatic diseases
  • 10. Levels of creatinine and/or blood urea nitrogen (BUN) were out of normal range or suffering from kidney disease
  • 11. History of cancer
  • 12. Women who are pregnant, breast feeding, or planning to become pregnant during the trial, or positive in urine pregnancy test
  • 13. Participation in other clinical research trials

研究者

发起方
/A

相似试验

The effects of Hibiscus sabdariffa L calyces aqueous... | 临床试验